Vitiligo
Cross-source consensus on Vitiligo from 1 sources and 4 claims.
1 sources · 4 claims
How it works
Other
Highlighted claims
- In the 2020 claims sample, vitiligo prevalence was estimated at 0.19%. — Prevalence and comparative risk of mental health disorders in persons with vitiligo: a retrospective matched cohort study using claims data with expert-informed case validation
- The 2020 sample included 4,631 people with a vitiligo diagnosis in inpatient or outpatient care. — Prevalence and comparative risk of mental health disorders in persons with vitiligo: a retrospective matched cohort study using claims data with expert-informed case validation
- Vitiligo is described as a multifactorial autoimmune skin disease involving immune-mediated destruction of melanocytes. — Prevalence and comparative risk of mental health disorders in persons with vitiligo: a retrospective matched cohort study using claims data with expert-informed case validation
- Extrapolation from the claims sample suggested about 148,437 people with vitiligo in Germany. — Prevalence and comparative risk of mental health disorders in persons with vitiligo: a retrospective matched cohort study using claims data with expert-informed case validation